{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Effects of the Use of Neuromuscular Blocking Agents on Acute Respiratory Distress Syndrome Outcomes: A Systematic Review

Purpose of Activity

To provide information about acute respiratory distress syndrome (ARDS) and best practices for its treatment, with a focus on the use of neuromuscular blocking agents (NMBAs).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify issues related to ARDS, including treatment options.
  2. Distinguish the use of NMBAs to treat ARDS.
Price: $17.95


  • AANP 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

This Activity is approved for 1.5 contact hour (s) of continuing education (which includes 1.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 18043162 This Activity was planned in accordance with AANP Accreditation Standards and Policies.

Awarded Advanced Pharmacology Hours

Test Code: JAANP0618
Published: Jun 2018
Expires: 7/1/2019
Passing Score: 13/18 (72%)
Authors: Samantha Paramore, AG-ACNP BC